Loading…
Azitra, Inc. is projected to rise to $0.2447 by 2027, a +18% move from its current price of $0.2066. AZTR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.1972 | $0.2064 | $0.216 | -0.09% |
| May 30 | $0.1934 | $0.2062 | $0.22 | -0.18% |
| May 31 | $0.1904 | $0.206 | $0.223 | -0.27% |
| Jun 1 | $0.1879 | $0.2059 | $0.2255 | -0.36% |
| Jun 2 | $0.1857 | $0.2057 | $0.2277 | -0.45% |
| Jun 3 | $0.1838 | $0.2055 | $0.2298 | -0.54% |
| Jun 4 | $0.182 | $0.2053 | $0.2316 | -0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.182 | $0.2053 | $0.2316 | -0.63% |
| Week 2 | $0.172 | $0.204 | $0.2419 | -1.26% |
| Week 3 | $0.1645 | $0.2027 | $0.2498 | -1.88% |
| Week 4 | $0.1583 | $0.2014 | $0.2564 | -2.50% |
| Week 5 | $0.1529 | $0.2002 | $0.2621 | -3.11% |
| Week 6 | $0.148 | $0.1989 | $0.2673 | -3.72% |
| Week 7 | $0.1437 | $0.1977 | $0.272 | -4.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on precision dermatology. It develops therapies for skin diseases in the United States using engineered proteins and topical live biotherapeutic products.
Its programs include ATR-04, ATR-12, and ATR-01, all based on genetically modified strains of S. epidermidis in various trial stages, including Phase 1/2 for the papulopustular rash in cancer patients on EGFR inhibitors, Phase 1b/2a for Netherton syndrome, and IND-enabling work for ichthyosis vulgaris. Azitra has a joint development agreement with Bayer for the identification and characterization of S.
epidermidis strains for topical formulations. The company was incorporated in 2014 and is headquartered in Branford, Connecticut.
Azitra, Inc. is a healthcare asset with a current price around $0.2039 and a market capitalization near $3.3M. It ranks 5421 by market cap among publicly traded entities. The near-term picture reflects a flat to modestly rising trajectory with a 2026 average price of $0.2039, within a $0.137 to $0.2431 range and a 0% return expectation, remaining sentiment NEUTRAL.
The longer horizon envisions a gradual ascent, with notable milestones in 2030, 2040, and 2050.
A major floor 33.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.9% below — buyers have tended to step in here.
The nearest ceiling, 23.9% above — a clean break opens room to run.
A major ceiling 58.8% above — clearing it would confirm fresh momentum.
Key AZTR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AZTR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.206 | Buy | $0.2055 | Buy |
| MA 10 | $0.1992 | Buy | $0.2067 | Sell |
| MA 20 | $0.2203 | Sell | $0.2126 | Sell |
| MA 50 | $0.2241 | Sell | $0.2216 | Sell |
| MA 100 | $0.2269 | Sell | $0.2854 | Sell |
| MA 200 | $0.4152 | Sell | $2.27 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.97 | Neutral |
| Stoch RSI (14) | 69.25 | Neutral |
| CCI (20) | -41.91 | Neutral |
| Williams %R (14) | -53.45 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -11.54 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 46.55 | Neutral |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 60.52 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.21 | Sell |
| ADX (14) | 15.23 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is BEARISH with an RSI(14) of 40. The 50-day simple moving average sits at $0.2225, while the 200-day moving average is at $0.4242. Immediate support is at $0.18 and resistance at $0.256.
The stock’s 30-day range spans from $0.1488 up to $0.2794, indicating a wide trading band and a potential test of the defined support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.137 | $0.2066 | $0.2432 | 0% | Neutral | |
| $0.1815 | $0.2447 | $0.3556 | +18% | Neutral | |
| $0.1775 | $0.2513 | $0.3856 | +22% | Bullish | |
| $0.176 | $0.2599 | $0.416 | +26% | Bullish | |
| $0.1665 | $0.2554 | $0.4234 | +24% | Bullish | |
| $0.137 | $0.2176 | $0.372 | +5% | Neutral | |
| $0.1452 | $0.2384 | $0.4188 | +15% | Neutral | |
| $0.1467 | $0.2486 | $0.4477 | +20% | Bullish | |
| $0.1679 | $0.2935 | $0.5404 | +42% | Bullish | |
| $0.2011 | $0.3622 | $0.6808 | +75% | Bullish | |
| $0.1918 | $0.3982 | $0.8154 | +93% | Bullish | |
| $0.2583 | $0.574 | $1.32 | +178% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.137 | $0.2066 | $0.246 | +0.00% |
| June 2026 | $0.1724 | $0.2055 | $0.2528 | -0.55% |
| July 2026 | $0.1574 | $0.1903 | $0.2393 | -7.39% |
| August 2026 | $0.1546 | $0.189 | $0.2417 | -0.68% |
| September 2026 | $0.1545 | $0.1907 | $0.2472 | +0.91% |
| October 2026 | $0.1422 | $0.177 | $0.2323 | -7.17% |
| November 2026 | $0.1353 | $0.1697 | $0.225 | -4.17% |
| December 2026 | $0.1437 | $0.1816 | $0.2432 | +7.04% |
Click any year to see its month-by-month AZTR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Azitra, Inc.'s 2026 outlook centres on $0.2066, within a $0.137 to $0.2432 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AZTR could reach as high as $0.3556, with a base case around $0.2447 and support toward $0.1815 — roughly +18% from $0.2066. A consolidation phase looks the most probable path here.
Expect AZTR to range from $0.1775 to $0.3856 through 2028. The $0.2513 average target implies a +22% move from current prices. That is up +3% on the projected 2027 average. Momentum favours further upside here.
The AZTR price prediction for 2029 points to an average of $0.2599 (low $0.176, high $0.416) — a potential gain of +26% on today's $0.2066. Buyers look set to stay in control over this stretch.
In 2030, AZTR is projected to trade between $0.1665 and $0.4234, averaging $0.2554 — a potential gain of +24% from today's $0.2066. That is -2% versus the projected 2029 average. Momentum favours further upside here.
Azitra, Inc.'s 2031 outlook centres on $0.2176, within a $0.137 to $0.372 range. That is -15% versus the projected 2030 average. That marks a +5% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AZTR could reach as high as $0.4188, with a base case around $0.2384 and support toward $0.1452 — roughly +15% from $0.2066. Price action looks broadly range-bound.
Expect AZTR to range from $0.1467 to $0.4477 through 2033. The $0.2486 average target implies a +20% move from current prices. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The AZTR price prediction for 2034 points to an average of $0.2935 (low $0.1679, high $0.5404) — a potential gain of +42% on today's $0.2066. Momentum favours further upside here.
In 2035, AZTR is projected to trade between $0.2011 and $0.6808, averaging $0.3622 — a potential gain of +75% from today's $0.2066. That is up +23% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Azitra, Inc.'s 2040 outlook centres on $0.3982, within a $0.1918 to $0.8154 range. That is up +10% on the projected 2035 average. That marks a +93% change versus current levels. Momentum favours further upside here.
By 2050, AZTR could reach as high as $1.32, with a base case around $0.574 and support toward $0.2583 — roughly +178% from $0.2066. Buyers look set to stay in control over this stretch.
Investing $1,000 in AZTR today (≈ 4,840.271055 AZTR) could be worth
$2,778.3
+$1,778.3 (+178%) by 2050 · US Dollar
Based on the average projected AZTR price of $0.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AZTRwould be worth at today's price.
$1,000 invested in AZTR on May 27, 2025 (≈ 517.241458 AZTR) would be worth
$106.86
-$893.14 (-89.3%) today · 0.11× · US Dollar
Based on a AZTR entry price of $1.93 vs. today's $0.2066.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.197 | $1,048.73 | +4.9% |
| 1 month ago | $0.224 | $922.32 | -7.8% |
| 3 months ago | $0.182 | $1,135.16 | +13.5% |
| 6 months ago | $0.377 | $548.01 | -45.2% |
| 1 year ago | $1.93 | $106.86 | -89.3% |
| All time (2.9y) ago | $988 | $0.21 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AZTR forecast.
Our base-case forecast reaches $0.41 around 2050.
Implied market cap at $0.41: $6.64M
The multi-year forecast shows a bullish trajectory from 2027 onward, with the 2030 average price at $0.252 and a max of $0.424, delivering an estimated ROI of 23.6% and a bullish sentiment. By 2040, the average is $0.3962 with a max of $0.8284, an estimated ROI of 94.3% and a bullish sentiment. By 2050, the average rises to $0.5691 with a max of $1.31 and a strong estimated ROI of 179.1% in a bullish backdrop.
These figures illustrate a path toward higher pricing in the long run, but they remain estimates, not guarantees, and carry inherent uncertainty. The forecast also shows interim years with varying ROIs and sentiment but consistently bullish by the end of the horizon.
Tap a question to reveal the answer.
2030: avg $0.252, min $0.1616, max $0.424, ROI 23.6%, sentiment BULLISH.
Forecasts show potential upside with a 2030 avg of $0.252 and a 2050 max of $1.31, yielding ROIs up to 179.1%. Near term, 2026 is Neutral with ROI 0% and a price around $0.2039. These are estimates and not guarantees, and risk is inherent in micro-cap healthcare stocks.
The 2050 forecast max is $1.31, which exceeds $1, indicating potential above-$1 levels in the long run according to the provided projections.
2026: min $0.137, avg $0.2039, max $0.2431, ROI 0%, sentiment NEUTRAL.
Azitra, Inc. Community Discussion
0Share your Azitra, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.